
### [NCIT:C3174](http://purl.obolibrary.org/obo/NCIT_C3174)
**Label:** Chronic Myelogenous Leukemia, BCR-ABL1 Positive

**Subclasses:** [NCIT:C7303](http://purl.obolibrary.org/obo/NCIT_C7303) (Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9129](http://purl.obolibrary.org/obo/NCIT_C9129) (Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C9070](http://purl.obolibrary.org/obo/NCIT_C9070) (Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3173](http://purl.obolibrary.org/obo/NCIT_C3173) (Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9128](http://purl.obolibrary.org/obo/NCIT_C9128) (Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C7885](http://purl.obolibrary.org/obo/NCIT_C7885) (Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9110](http://purl.obolibrary.org/obo/NCIT_C9110) (Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3175](http://purl.obolibrary.org/obo/NCIT_C3175) (Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C7320](http://purl.obolibrary.org/obo/NCIT_C7320) (Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive), 

**Class expressions from DL-Learner:**

- Thing 55.92%
- [NCIT:C36341](http://purl.obolibrary.org/obo/NCIT_C36341) (Signal Transduction Pathway Deregulation) 53.77%
- [NCIT:C38347](http://purl.obolibrary.org/obo/NCIT_C38347) (P13K-AKT Pathway Deregulation) 50.94%
- [NCIT:C38346](http://purl.obolibrary.org/obo/NCIT_C38346) (MYC Pathway Deregulation) 50.94%
- [NCIT:C38345](http://purl.obolibrary.org/obo/NCIT_C38345) (JUN Pathway Deregulation) 50.94%
- [NCIT:C38344](http://purl.obolibrary.org/obo/NCIT_C38344) (RAS-RAF Pathway Deregulation) 50.94%
- [NCIT:C38343](http://purl.obolibrary.org/obo/NCIT_C38343) (JAK-STAT Pathway Deregulation) 50.94%
- Error20 50.94%
- Error15 50.94%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C39583](http://purl.obolibrary.org/obo/NCIT_C39583) (FAS Apoptosis Pathway Deregulation))) 44.25%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C36339](http://purl.obolibrary.org/obo/NCIT_C36339) (Cell Cycle Deregulation))) 44.25%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) 41.98%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C39816](http://purl.obolibrary.org/obo/NCIT_C39816) (Infiltrating Bladder Urothelial Carcinoma with Squamous Differentiation))) 41.98%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C39815](http://purl.obolibrary.org/obo/NCIT_C39815) (Cellular Congenital Mesoblastic Nephroma))) 41.98%
- [NCIT:C36340](http://purl.obolibrary.org/obo/NCIT_C36340) (Molecular Pathway Deregulation) and (not ([NCIT:C39814](http://purl.obolibrary.org/obo/NCIT_C39814) (Classic Congenital Mesoblastic Nephroma))) 41.98%


